Keith Vrbicky, MD, Enrolls First U.S. Participant in Moderna’s Phase 2 COVID-19 Vaccine Clinical Trial

The first participant in the Moderna Phase 2 COVID-19 vaccine trial was enrolled this morning by Keith Vrbicky, MD, Meridian (now Velocity Clinical Research) Principal Investigator in Norfolk, NECongratulations to Moderna for making remarkable progress on its mRNA vaccine against novel coronavirus. 📰 Full release:

Posted in

Quality. Continuity. Velocity.